We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+19.59%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.49B
AUM Growth
+$149M
Cap. Flow
-$38.7M
Cap. Flow %
-1.56%
Top 10 Hldgs %
20.52%
Holding
268
New
26
Increased
99
Reduced
104
Closed
25

Top Buys

Rank Stock Value
1
LPX icon
Louisiana-Pacific
LPX
+$19.9M
2
LITE icon
Lumentum
LITE
+$15.1M
3
VKTX icon
Viking Therapeutics
VKTX
+$13.8M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$12.7M
5
TREE icon
LendingTree
TREE
+$12M

Top Sells

Rank Stock Value
1
IMGN
Immunogen Inc
IMGN
+$51.7M
2
SMCI icon
Super Micro Computer
SMCI
+$47.1M
3
CBAY
Cymabay Therapeutics
CBAY
+$25.2M
4
PRVA icon
Privia Health
PRVA
+$14M
5
SMPL icon
Simply Good Foods
SMPL
+$13.6M

Sector Composition

Rank Sector Weight
1 Technology 25.01%
2 Healthcare 24.99%
3 Industrials 19.42%
4 Financials 9.95%
5 Consumer Discretionary 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONTO icon
26
Onto Innovation
ONTO
$13.9B
$28.1M 1.13%
155,252
+1,653
+1% +$279K
NVEE
27
DELISTED
NV5 Global
NVEE
$27.8M 1.12%
1,135,524
-30,872
-3% -$801K
ITCI
28
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$27.8M 1.12%
401,611
+57,791
+17% +$3.97M
MDGL icon
29
Madrigal Pharmaceuticals
MDGL
$12.8B
$27.1M 1.09%
101,623
+53,901
+113% +$12.7M
MTSI icon
30
MACOM Technology Solutions
MTSI
$20.4B
$27M 1.09%
282,658
+2,563
+0.9% +$227K
FOUR icon
31
Shift4
FOUR
$3.99B
$26.7M 1.07%
403,755
-97,102
-19% -$7.3M
FORM icon
32
FormFactor
FORM
$8.23B
$26.2M 1.05%
573,523
+11,630
+2% +$484K
COLL icon
33
Collegium Pharmaceutical
COLL
$1.17B
$26M 1.05%
669,512
+3,416
+0.5% +$120K
BWIN
34
Baldwin Insurance Group
BWIN
$2.66B
$25.9M 1.04%
893,592
+5,375
+0.6% +$141K
MC icon
35
Moelis & Co
MC
$5.02B
$25.7M 1.03%
452,825
+1,782
+0.4% +$97.3K
VKTX icon
36
Viking Therapeutics
VKTX
$4.31B
$25.5M 1.03%
+311,007
New +$13.8M
AX icon
37
Axos Financial
AX
$5.66B
$24.7M 0.99%
457,424
+100,899
+28% +$5.31M
SVV icon
38
Savers
SVV
$1.53B
$24.2M 0.97%
1,252,738
+86,262
+7% +$1.61M
AIR icon
39
AAR Corp
AIR
$5.38B
$24M 0.97%
400,951
+6,217
+2% +$387K
LPX icon
40
Louisiana-Pacific
LPX
$5.17B
$23.2M 0.93%
+276,306
New +$19.9M
RARE icon
41
Ultragenyx Pharmaceutical
RARE
$2.88B
$22.8M 0.92%
488,138
+6,000
+1% +$283K
RMBS icon
42
Rambus
RMBS
$11B
$22.5M 0.91%
364,664
+5,971
+2% +$378K
BBIO icon
43
BridgeBio Pharma
BBIO
$15.9B
$21.6M 0.87%
699,083
+13,544
+2% +$461K
ARHS icon
44
Arhaus
ARHS
$1.09B
$21.4M 0.86%
1,391,683
+14,549
+1% +$187K
BJRI icon
45
BJ's Restaurants
BJRI
$1.42B
$21.2M 0.85%
586,261
-151
-0% -$5.25K
HLI icon
46
Houlihan Lokey
HLI
$9.67B
$21.2M 0.85%
165,067
+855
+0.5% +$106K
PI icon
47
Impinj
PI
$4.21B
$21.1M 0.85%
163,989
+43,300
+36% +$4.55M
AGYS icon
48
Agilysys
AGYS
$3B
$20.9M 0.84%
247,867
+44,122
+22% +$3.57M
TMCI icon
49
Treace Medical Concepts
TMCI
$279M
$20.4M 0.82%
1,561,893
+114,304
+8% +$1.52M
EYE icon
50
National Vision
EYE
$1.66B
$19.6M 0.79%
885,787
+10,157
+1% +$214K
1
2
3 4 5

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Emerald Advisers held 268 positions worth $2.49B, up 6.4% from $2.34B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Emerald Advisers's Q1 2024 filing shows 26 new, 99 increased, 104 reduced and 25 closed positions. Its largest new stake was Louisiana-Pacific: 276,306 shares worth $23.2M. The largest sale was Immunogen Inc, an estimated $51.7M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Emerald Advisers's largest Q1 2024 buy was Louisiana-Pacific: 276,306 shares worth $23.2M.
  • Emerald Advisers added most to Madrigal Pharmaceuticals in Q1 2024, an estimated $12.7M increase.
  • Emerald Advisers's biggest Q1 2024 reduction was Super Micro Computer, cutting an estimated $47.1M.
  • Emerald Advisers fully exited Immunogen Inc in Q1 2024, selling an estimated $51.7M.
  • Emerald Advisers's ten largest holdings make up 21% of its $2.49B portfolio in Q1 2024.
  • Emerald Advisers opened 26 new positions and closed 25 in Q1 2024.
  • Emerald Advisers's portfolio value rose 6.4% quarter-over-quarter to $2.49B.

Based on Emerald Advisers's 13F filing for Q1 2024, filed 8 May 2024.